COX-2-PGE2-EPs in gynecological cancers

Abstract

Purpose Nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors (COXibs) inhibit the progression of endometrial cancer, ovarian cancer and cervical cancer. However, concerning the adverse effects of NSAIDs and COXibs, it is still urgent and necessary to explore novel and specific anti-inflammation targets for potential chemoprevention. The signaling of cyclooxygenase 2-prostaglandin E 2-prostaglandin E 2 receptors (COX-2-PGE 2-EPs) is the central inflammatory pathway involved in the gynecological carcinogenesis. Methods Literature searches were performed to the function of COX-2-PGE 2-EPs in gynecological malignancies. Results This review provides an overview of the current knowledge of COX-2-PGE 2-EPs signaling in endometrial cancer, ovarian cancer and cervical cancer. Many studies demonstrated the upregulated expression of the whole signaling pathway in gynecological malignancies and some focused on the function of COX-2 and cAMP-linked EP2/EP4 and EP3 signaling pathway in gynecological cancer. By contrast, roles of EP1 and the exact pathological mechanisms have not been completely clarified. The studies concerning EP receptors in gynecological cancers highlight the potential advantage of combining COX enzyme inhibitors with EP receptor antagonists as therapeutic agents in gynecological cancers. Conclusion EPs represent promising anti-inflammation biomarkers for gynecological cancer and may be novel treatment targets in the near future.

Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer

“…PGE2 is the most abundant prostaglandin in humans and is known as a critical mediator in inflammation. The functions of PGE2 are mainly facilitated by four specific G-protein-coupled receptors (EP1-EP4) with various signaling pathways ( 43 ). Sales and colleagues reported that, in addition to the expression of COX-2 and production of PGE2, cervical tumors express EP2 and EP4 receptors, suggesting an autocrine/paracrine regulation of the neoplastic cell function ( 42 ).…”

Lipid Signaling in Ocular Neovascularization

“…PGE 2 is a potent angiogenic lipid mediator exerting its effects through G protein-coupled receptors (EP1-4) via autocrine and paracrine signaling. EP1 is coupled to Gαq/11, modulating intracellular Ca 2+ levels [141]. EP2 and EP4 are coupled with Gαs activating adenylate cyclase, which subsequently produces cyclic adenosine monophosphate (cAMP) [142].…”

Important players in carcinogenesis as potential targets in cancer therapy: an update

“…This indicates the involvement of this pathway in processes that facilitate cancer cell survival. Another mechanism contributing to cancer development in which cyclooxygenase 2 is involved is the complex process involving the COX-2/PGE2/EP4 axis, as a result of which metalloproteinase 9 expression is stimulated [36][37][38]. MMP-9 causes proteolytic activation of TGF-β, which begins the induction of epithelial-mesenchymal transformation (EMT).…”